Chandra Bhagat Pharma Ltd. Approves Un-Audited Financial Results for H1 2025

Chandra Bhagat Pharma Ltd. announced the outcome of their Board Meeting held on 13th November, 2025. The Board approved the Un-Audited Financial Result of the Company for the half year ended on 30th September, 2025. The 'Trading Window' for trading in the shares of the Company will open after 48 hours from the Announcement of Financial Statement for the Directors and Key Managerial Personnel/Designated Employees/ Connected person of the Company as defined in the code of conduct for prohibition of Insider Trading of the Company. The Limited Review Report was furnished by the Statutory Auditor of the Company in compliance with Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015.